SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001171520-21-000076
Filing Date
2021-02-12
Accepted
2021-02-12 15:42:00
Documents
1
Group Members
HABIB KAIROUZJOSHUA RUCHMARK LESCHLYRHO CAPITAL PARTNERS LLCRHO VENTURES VI, L.P.RMV VI, L.L.C.

Document Format Files

Seq Description Document Type Size
1 eps9484.htm SC 13G/A 163596
  Complete submission text file 0001171520-21-000076.txt   165502
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Subject) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87880 | Film No.: 21626694
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 West 57th Street 23rd Floor New York NY 10019
Business Address 152 West 57th Street 23rd Floor New York NY 10019 (212) 751-6677
RHO Ventures VI LP (Filed by) CIK: 0001419636 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A